Study of immune response to BK virus in kidney transplant patients
Treatments studied
Part of Immune system & allergy, Infections, Kidney & urinary clinical trials.
This study looks at how the immune system reacts to the BK virus in people who have had a kidney transplant. It may help doctors understand why some patients develop the virus in their blood and how to better manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your legal guardian must agree to the study.
- You must be covered by the French national social security system.
- You must be at least 7 years old.
- You must weigh at least 12 kilograms (about 26 pounds).
- You must have had a kidney transplant within the last 12 months.
- Some participants must have the BK virus in their blood, and some must not. Healthy adults are also needed as a comparison group.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
This early-phase study tests whether immune cells made from a donor (T cells) can treat BK virus infection in people whose immune system is weak after a stem cell transplant or chemotherapy. It may help control the virus causing bladder/urinary symptoms.
This study looks at how memory B cells (a type of immune cell) relate to antibodies against HLA in people waiting for a kidney transplant. It aims to better understand immune responses, which could help improve transplant matching and outcomes.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.
This study is creating a registry to learn how the immune system responds to BK virus in people who have recently received a kidney transplant from a deceased donor. Researchers hope this information will help improve treatment for BK virus infections.
Hear when a new BK Polyomavirus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.